Therapeutic monoclonal antibodies
- 1 February 2000
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 355 (9205) , 735-740
- https://doi.org/10.1016/s0140-6736(00)01034-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- REDUCTION OF ACUTE RENAL ALLOGRAFT REJECTION BY DACLIZUMAB1Transplantation, 1999
- Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk InfantsPediatrics, 1998
- In vivo and In vitro production of monoclonal antibodies: Current possibilities and future perspectivesResearch in Immunology, 1998
- HOW DO MONOCLONAL ANTIBODIES INDUCE TOLERANCE? A Role for Infectious Tolerance?Annual Review of Immunology, 1998
- Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipientsThe Lancet, 1997
- A PHASE I TRIAL OF HUMANIZED ANTI-INTERLEUKIN 2 RECEPTOR ANTIBODY IN RENAL TRANSPLANTATION1Transplantation, 1997
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975